Hyperimmune immunoglobulin for people with COVID-19
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:
Using a living systematic review approach, to assess whether hyperimmune immunoglobulin therapy is effective and safe in the treatment of people with COVID‐19; and to maintain the currency of the evidence.
Bibliographic Details
| Main Authors: |
Kimber, C,
Valk, SJ,
Chai, KL,
Piechotta, V,
Iannizzi, C,
Monsef, I,
Wood, EM,
Lamikanra, AA,
Roberts, DJ,
McQuilten, Z,
So-Osman, C,
Estcourt, LJ,
Skoetz, N |
|---|
| Format: | Journal article
|
|---|
| Language: | English |
|---|
| Published: |
Cochrane Collaboration
2021
|
|---|